Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001654954-16-001290
Filing Date
2016-08-09
Accepted
2016-08-09 12:14:20
Documents
1
Period of Report
2016-07-08
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sbfm_8ka.htm 8-K/A 24109
  Complete submission text file 0001654954-16-001290.txt   25443
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-52898 | Film No.: 161816982
SIC: 8731 Services-Commercial Physical & Biological Research